DNA diagnostics is a cutting edge method which is set to revolutionize the
field of medical diagnostics. This technique enables medical professionals to
identify various diseases, such as cancer, infectious diseases, and myogenic
disorders, and to determine the appropriate treatment for the same. It is also
used for clinical diagnostic confirmation and in prenatal diagnostics. The
concept of DNA diagnostics has evolved via the breakthrough human genome
project that resulted in the discovery of various disease-causing agents. The
DNA diagnostics market is expected to generate 19 billion by 2020, growing at
a CAGR of 9.8% during the analysis period. Technological development has
played a major role in improving DNA diagnostic platforms and techniques.

Some of the significant technologies which incorporate DNA diagnostics include
polymerase chain reaction (PCR), microarray techniques, sequencing technology
and mass spectrometry; these technologies are used for sample preparation, DNA
isolation etc. Technological developments, which have led to improvements in
these methodologies, drive the growth of the DNA diagnostics market. The use
of DNA diagnostic methods in prenatal diagnostics and clinical confirmation
has also boosted market growth. The DNA diagnostics market is expected to
experience a growth spurt in the foreseeable future. Innovations in product
design and technology have prompted doctors and researchers to shift their
focus from traditional diagnostic methods to personalized medicines. The
increased adoption of the personalized medicines approach would positively
impact the DNA diagnostics market in the foreseeable future. Next generation
sequencing is a powerful tool for decoding a number of human diseases,
including various forms of cancer. Next generation sequencing reduces the cost
of sequencing and increases the throughput. The optimization of sequencing
technology could greatly impact the DNA diagnostics market.

The report breaks the market into segments based on product type, technology,
application, end users and geography. Based on product types, the market is
segmented into instruments, reagents and service & software. The instruments
segment holds the dominant share in the market, due to improved healthcare
facilities, availability of user-friendly instruments, its competitive cost
structure, reliability, size and the growing demand for it in the DNA
diagnostics market. However, the service & software segment is expected to
grow at a steady rate in the near future due to technological advancements and
the incorporation of information technology in the DNA diagnostics market.
There are several technologies used in the DNA diagnostics market; these
include PCR, mass spectrometry, sequencing technology, in-situ hybridization
and microarrays. PCR holds the dominant share due to its frequent usage in
diagnostic procedures such as sample preparation, separation and isolation of
DNA from collected samples. The DNA diagnostics market is also segmented based
on its application in various diseases such as oncology, infectious diseases
and myogenic disorders. The oncology segment leads the market and is followed
by infectious diseases due to the rising incidence of these diseases and
growing elderly population. In terms of geography, the market is segmented
into North America, Asia Pacific, Europe and LAMEA. North America holds the
dominant share in the market due to the increased adoption of the DNA
diagnostics technology and the high prevalence of chronic and infectious
diseases. Companies profiled in the report include Roche Diagnostics, Bayer
Diagnostic, Sysmex, Abbott laboratories, Gene-probe Inc., Cephide, Illumina,
Inc., Bio-Rad Laboratories, Thermo Fisher Scientific, Johnson and Johnson, and
Novartis.

KEY BENEFITS

An in-depth analysis of various regions would provide a clear
understanding of current and future trends so that companies can make region
specific plans

The report studies the application of next generation sequencing
technology and biotechnology and their impact on the DNA diagnostics market

A comprehensive analysis of the factors that drive and restrict the growth
of the DNA diagnostics market is provided

Key regulatory guidelines in various regions which impact the DNA
diagnostics market are critically examined

A quantitative analysis of the current market and estimations through
2013-2020 are provided to showcase the financial caliber of the DNA
diagnostics market

Detailed analysis of the Asia-pacific region provides insights that would
enable companies to plan their business move strategically

Value chain analysis in the report gives a clear understanding of the
roles of the stakeholders involved in the supply chain of the DNA diagnostics
market

MARKET SEGMENTATION:

The DNA diagnostics market is segmented based on product type, technology,
application, end users and geography